Somewhat Favorable Media Coverage Somewhat Unlikely to Affect Gel Sol Technologies (SLGL) Share Price

Business



[ad_1]

Sol Gel Technologies logo "title =" Sol Gel Technologies logo "clbad =" companylogo "/> Media headlines about Sol Gel Technologies (NASDAQ: SLGL) have been trending somewhat positive, Accern reports. # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # Accelerated score of 0.07 on Accern 's Scale Accumulated score of 46.1940616478565 Out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company. </p> <p> SLGL stock traded up $ 0.11 during midday trading on Thursday, hitting $ 6.95 6,800 shares of the company's stock were exchanged, compared to its average volume of 35,279. and cap of $ 129.43 million and a price-to-earnings ratio of -1.38. Sol Gel Technologies has 1 year of $ 6.18 and a 1-year high of $ 16.48. </p> <p> Sol Gel Technologies (NASDAQ: SLGL) Last Posted on Tuesday, May 15th. The company reported ($ 0.39) earnings per share (EPS) for the quarter, missing the consensus estimate of ($ 0.33) by ($ 0.06). The business had revenue of $ 0.04 million during the quarter. Analysts predict that Sol Gel Technologies will post -2.05 EPS for the current fiscal year. </p> <p>                 A number of equities badysts recently commented on SLGL shares. Zacks Investment Research upgraded Sol Gel Technologies from a "sell" rating to a "hold" rating in a research report on Friday, June 22nd. ValuEngine upgraded Sol Gel Technologies from a "sell" rating to a "hold" rating in a research report on Wednesday, May 2nd. Finally, HC Wainwright started a survey on Sol Gel Technologies in a research report on Monday, July 16th. They set a "buy" rating and a $ 21.00 price on the stock. Two badysts have rated the stock with a hold and have issued a rating for the stock. The company currently has an average rating of "Buy" and a consensus target price of $ 19.00.</p> <p><strong> Sol Gel Technologies Company Profile </strong> </p> <p> Sol-Gel Technologies Ltd., a clinical-stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company's lead product candidates include TWIN and SIRS-T, which has completed Phase II clinical trials for the treatment of acne vulgaris; <br /><!--ViewCount:ArticleHistoryID=21915389&PostDate=2018-7-26&type=m&id=493202--></p> <p style= Receive News & Ratings for Sol Gel Daily Technologies </strong> – conceded daily summary of the latest news and badysts' ratings for Sol Gel Technologies and related companies MarketBeat.com's FREE daily email newsletter. </p> <p><!-- End Footer Opt-In --></p></div> </pre> [ad_2] <br /><a href=Source link

Tags

Powered by https://naaju.com/israel | Designed by Naaju
© Copyright 2024, All Rights Reserved